There are 859 resources available
210MO - Low dose nivolumab with TKI in mRCC: Dosing strategies, de-escalation and survival among self-paying patients in India
Presenter: Ajoy John
Session: Mini oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
211MO - EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)
Presenter: Eiji Kikuchi
Session: Mini oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 210MO and 211MO
Presenter: Yuji Miura
Session: Mini oral session: Genitourinary tumours
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Genitourinary tumours
Resources:
Webcast
Welcome and introduction
Presenter: Solange Peters
Session: Seagen - What’s next for ADCs in oncology?
Resources:
Webcast
Transformation of gastric cancer management in the past decade (from BSC to chemo to targeted + IO)
Presenter: Raghav Sundar
Session: Astellas - Personalising novel therapeutics for advanced gastric cancer
Resources:
Webcast
State of the art and perspectives
Presenter: Solange Peters
Session: Seagen - What’s next for ADCs in oncology?
Resources:
Webcast
Novel targeted therapy approaches in gastric cancer
Presenter: Elizabeth Smyth
Session: Astellas - Personalising novel therapeutics for advanced gastric cancer
Resources:
Webcast
Advances in integrin targeting
Presenter: Kenneth O'Byrne
Session: Seagen - What’s next for ADCs in oncology?
Resources:
Webcast
Claudin as a therapeutic target in gastric cancer
Presenter: Kohei Shitara
Session: Astellas - Personalising novel therapeutics for advanced gastric cancer
Resources:
Webcast